JournalJOURNAL / NEWSLETTER
Volume 29 Number 3 May 2013
201-207 Pharmacology of Aldosterone and the Effects of Mineralocorticoid Receptor Blockade on Cardiovascular Systems
208-216 C-Reactive Protein Gene Polymorphisms and the Risk of Atrial Fibrillation in a Chinese Population in Taiwan
217-225 Nitric Oxide Synthase 1 Adaptor Protein, an Emerging New Genetic Marker for QT Prolongation and Sudden Cardiac Death
226-234 Gene Therapy for Cardiac Arrhythmias
235-242 Warfarin Pharmacogenetics: New Life for an Old Drug
243-250 Prognostic Value of Functional Variables as Assessed by Gated Thallium-201 Myocardial Perfusion Single Photon Emission Computed Tomography for Major Adverse Cardiac Events in Patients with Coronary Artery Disease
251-260 Fenofibrate Modulates HO-1 and Ameliorates Endothelial Expression of Cell Adhesion Molecules in Systolic Heart Failure
261-270 High Flow-Mediated Vasodilatation Predicts Pulmonary Edema in Liver Transplant Patients
271-276 A Large Institutional Study on Outcomes and Complications after Transcatheter Closure of a Perimembranous-Type Ventricular Septal Defect in 890 Cases
277-280 Contrast-Induced Encephalopathy after Percutaneous Coronary Intervention
281-284 A Lethal Complication after Coronary Angiography in a Patient with Ehlers-Danlos Syndrome
285-287 Recurrent Supraventricular Tachycardia with a Different Retrograde Atrial Activation Sequence: What is the Mechanism?
288-290 Late Intervention-Related Complication - A Huge Subepicardial Hematoma
291-293 Information for Authors
TOP